About
Handheld fundus cameras (Aurora, next-gen Lumo launched 2025) with onboard AI diabetic-retinopathy screening. The Optomed Aurora-AEYE pairing is the first FDA-cleared handheld autonomous AI fundus camera.
HQ: Oulu, Finland
Funding
Public (Nasdaq Helsinki, IPO 2019)
Net sales EUR 17.1M, EBITDA EUR -3.5M (Q1 2026 interim).